This article
originally appeared in the May 2004 Harvard Heart Letter and is provided
courtesy of Harvard
Health Publications.
Timing, target critical for cholesterol-lowering
statins
Whether you are just starting a statin or have
been taking one for years, make sure you’re getting a “therapeutic
dose” and hit your target.
Many clinical studies drop into the ever-expanding pool
of medical knowledge without leaving a trace. A few make small ripples.
Every once in a while, a tsunami of a study immediately changes how doctors
practice their craft. That’s the case for the recent Pravastatin or
Atorvastatin Evaluation and Infection Therapy (PROVE IT) trial.
PROVE IT provided an unusual head-to-head comparison of two popular cholesterol-lowering
statins — standard-dose Pravachol (pravastatin) and high-dose Lipitor
(atorvastatin) — among people who had survived a heart attack or episode
of chest pain at rest (unstable angina). It showed that the further you
lower your level of “bad” LDL cholesterol after one of these
so-called acute coronary syndromes the better, even if your LDL is already
at or below the current recommended target.
These provocative results are already altering statin use. Some doctors
now set lower LDL goals for all their patients with cardiovascular disease
or at risk for it, not just for those who have had a heart attack or unstable
angina (see Ahead of the curve below).
Two other lessons from PROVE IT and similar studies are also finding
their way into practice. These have to do with the timing of statin therapy
and the dose.
| Ahead of the curve |
| Three weeks after the PROVE IT results appeared in the
New England Journal of Medicine, we asked Harvard Heart Letter editorial
board members what they thought LDL targets should be. Most had already
adopted a lower-is-better approach across the board. The survey results
certainly don’t represent what all doctors are doing. But they
do offer a clue to what soon-to-be-released updated guidelines might
look like. |
| Category |
Current LDL targets |
Heart Letter editors’ LDL targets
(range) |
| Heart attack or unstable angina in the past
10 days |
<100 |
<75 (65 to <100) |
| Heart attack or unstable angina in the past but currently stable |
<100 |
<75 (65 to <100) |
| One or more narrowed coronary arteries but no history of heart attack
or unstable angina |
<100 |
<82 (65 to <100) |
| No known coronary disease but high risk of having a heart attack in
the next 10 years (Framingham score >20%) |
<100 |
<82 (65 to <100) |
| No known coronary disease but intermediate risk of having a heart
attack in the next 10 years (Framingham score 10% –20%) |
<130 |
<113 (<90 to <130) |
| No known coronary disease and low risk of having a heart attack in
the next 10 years (Framingham score <10%) |
<160 |
<120 (<90 to <160) |
The right time
One of the surprises of PROVE IT was how quickly aggressive LDL-lowering
therapy paid off. In most previous statin trials, it took two years or more
to see differences between standard cholesterol-lowering strategies. In
PROVE IT, it took just 30 days for the investigators to start seeing fewer
heart attacks, strokes, deaths, and other problems in the super-low-LDL
group.
“
The sooner you start a statin after a heart attack or unstable angina,
the better,” says study leader Dr. Christopher P. Cannon, of Harvard’s
Brigham and Women’s Hospital. Until now, many doctors would wait for
a month or two after a heart attack to check fasting cholesterol levels
and, if high, to prescribe a low starting dose. With this leisurely process,
it might take six months or a year to get LDL levels where they need to
be — below 100 milligrams per deciliter (mg/dL). “By that time
many people would have missed out on the early benefit of a statin,” says
Dr. Cannon.
The right dose
Each statin comes in a range of doses (see Starting on statins below).
Conventional wisdom suggests starting with the lowest dose and, if that
doesn’t do the trick, gradually working your way up to a stronger
one that gets your LDL below your target. It’s a prudent strategy,
aimed as much at minimizing your chance of having a bad reaction as it is
at hitting your LDL target. But it isn’t the best for your cardiovascular
health.
The go-slow approach doesn’t quickly stabilize so-called vulnerable
plaques. These leaky pockets of cholesterol, white blood cells, and debris
embedded in the lining of blood vessels are thought to be the source
of the blood clots that cause heart attacks and unstable angina. Faster,
deeper
cholesterol lowering is more effective at sealing the leaks.
The other problem with starting low is that more than half of people
who take a statin don’t meet their LDL target. Some of this gap occurs
because people forget to take the medication or decide not to take it. But
some is also due to what’s called clinical inertia — doctors’ failure
to intensify treatment when needed.
| Starting on statins |
| Instead of starting with the lowest-dose statin, begin
with one that drops LDL by 30% –40%. |
| Drug |
Pill strengths (milligrams) |
Standard or therapeutic dose (milligrams/day) |
LDL reduction |
| Crestor (rosuvastatin) |
5, 10, 20, 40 |
5–10 |
39%–45% |
| Lescol (fluvastatin) |
20, 40, 80 |
40–80 |
25%–31% |
| Lipitor (atorvastatin) |
10, 20, 40, 80 |
10 |
39% |
| Mevacor (lovastatin) |
10, 20, 40 |
40 |
31% |
| Pravachol (pravastatin) |
10, 20, 40, 80 |
40 |
34% |
| Zocor (simvastatin) |
5, 10, 20, 40, 80 |
20–40 |
35%–41% |
The right strategy
How best to use statins is still evolving. Here’s what we’ve
learned from the latest trials. Other refinements are in the offing:
Starting
a high-dose statin before leaving the hospital after a heart attack or episode
of unstable angina and sticking with it can help prevent
a future heart attack or stroke or keep you from dying prematurely.
If
you are just starting a statin or taking one over the long term, your
prescription needs to be strong enough to drive your LDL down to your
target.
|